Tolvaptan attenuates atrial remodeling in rats undergoing chronic intermittent hypoxia via miRNA-21 
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.0253-3758.2019.08.005
   		
        
        	
        		- VernacularTitle: 托伐普坦通过调控微小RNA-21改善大鼠心房重构 
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Zuowang MA
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Kai ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Weiding WANG
			        		
			        		;
		        		
		        		
		        		
			        		Ruimeng LIU
			        		
			        		;
		        		
		        		
		        		
			        		Yuanyuan XU
			        		
			        		;
		        		
		        		
		        		
			        		Yue ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Meng YUAN
			        		
			        		;
		        		
		        		
		        		
			        		Guangping LI
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Atrial fibrillation;
			        		
			        		
			        		
				        		MicroRNAs;
			        		
			        		
			        		
				        		Atrial remodeling;
			        		
			        		
			        		
				        		Tolvaptan
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Cardiology
	            		
	            		 2019;47(8):614-621
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Objective:To investigate the effects and potential mechanisms of tolvaptan on chronic intermittent hypoxia (CIH)-induced atrial remodeling in rats.
				        	
				        
				        	Methods:A total of 45 Sprague-Dawley rats were divided into 3 groups by the random number table: control group, CIH group (6 h/d for 30 days), CIH plus tolvaptan group (8 mg·kg-1·d-1 per gavage for 30 days). Echocardiography examination was performed after 30 days. Thereafter, 5 rats were randomly chosen for histology evaluation, 5 for molecular biological examinations and another 5 rats underwent isolated heart electrophysiology study in each group. Protein and mRNA expression levels of miRNA-21, Spry1, PTEN, ERK/p-ERK, MMP-9, PI3K, AKT/p-AKT were detected.
				        	
				        
				        	Results:Compared to the rats in control group, rats in the CIH group showed higher atrial interstitial collagen deposition (P<0.001), increased atrial fibrillation inducibility (P=0.022). The results of immunohistochemistry staining showed that the mean optical density (MOD) of ERK, p-ERK and MMP-9 were significantly increased (all P<0.05), the MOD of Spry1 and PTEN were significantly decreased (both P<0.05), above changes could be significantly reversed by cotreatment with tolvaptan. No significant differences were detected in PI3K and AKT among the three groups (P>0.05). In addition, compared with rats in control group, mRNA levels of miRNA-21, MMP-9, PI3K, AKT, and protein levels of ERK, p-ERK, MMP-9 were significantly increased in CIH group(all P<0.05), whereas protein levels of Spry1, PI3K, p-AKT were significantly decreased (all P<0.05). Above changes could be significantly attenuated.
				        	
				        
				        	Conclusions:CIH induces significant atrial remodeling in this rat model, which can be attenuated by tolvaptan possibly through modulating miRNA-21/Spry1/ERK/MMP-9 and miRNA-21/PTEN/PI3K/AKT signaling pathways.